Alterity Therapeutics Ltd - Understand $athe stock

$ATHE Market Cap: $15.96 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$136.0K

TTM

Gross Margin

Net Earnings

-$26.58M

TTM

Current Assets

$21.99M

Q4 2023

Current Liabilities

$4.493M

Q4 2023

Current Ratio

489.51%

Q4 2023

Total Assets

$22.19M

Q4 2023

Total Liabilities

$4.569M

Q4 2023

Book Value

$17.62M

Q4 2023

Cash

$12.32M

Q4 2023

P/E

-0.6006

Nov 29, 2024 EST

Free Cash Flow

-$28.12M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	$16.44K	$2.500K	$20.68K	$17.12K	$108.5K	$201.2K	$132.4K	$142.7K	$176.8K	$360.0K	$150.0K	$190.0K	$160.0K	$220.0K	$430.0K	$490.0K	$510.0K	$1.050M	$2.650M	$2.320M	$1.820M	$790.0K	$520.0K	$80.00K	$0.00
YoY Change	557.6%	-87.91%	20.79%	-84.23%	-46.05%	51.94%	-7.19%	-19.33%	-50.88%	140.0%	-21.05%	18.75%	-27.27%	-48.84%	-12.24%	-3.92%	-51.43%	-60.38%	14.22%	27.47%	130.38%	51.92%	550.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Revenue	$16.44K	$2.500K	$20.68K	$17.12K	$108.5K	$201.2K	$132.4K	$142.7K	$176.8K	$360.0K	$150.0K	$190.0K	$160.0K	$220.0K	$430.0K	$490.0K	$510.0K	$1.050M	$2.650M	$2.320M	$1.820M	$790.0K	$520.0K	$80.00K	$0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Selling, General & Admin	$5.222M	$5.824M	$7.157M	$3.675M	$4.601M	$4.544M	$4.189M	$3.853M	$4.857M	$5.800M	$4.200M	$3.590M	$4.080M	$4.990M	$5.490M	$6.440M	$5.940M	$4.440M	$5.650M	$4.860M	$3.050M	$2.150M	$680.0K	$190.0K	$0.00
YoY Change	-10.34%	-18.62%	94.76%	-20.13%	1.25%	8.47%	8.74%	-20.69%	-16.25%	38.1%	16.99%	-12.01%	-18.24%	-9.11%	-14.75%	8.42%	33.78%	-21.42%	16.26%	59.34%	41.86%	216.18%	257.89%
% of Gross Profit
Research & Development	13.20M auds	14.75M auds	$12.28M	$10.10M	$12.98M	$6.698M	$5.700M	$9.585M	$12.30M	$14.91M	$8.200M	$4.230M	$2.330M	$90.00K	$2.220M	$5.760M	$4.490M	$7.610M	$7.690M	$5.240M	$1.720M	$2.480M	$2.360M	$420.0K	$0.00
YoY Change	-10.49%	20.04%	21.64%	-22.22%	93.84%	17.5%	-40.53%	-22.06%	-17.52%	81.83%	93.85%	81.55%	2488.89%	-95.95%	-61.46%	28.29%	-41.0%	-1.04%	46.76%	204.65%	-30.65%	5.08%	461.9%
% of Gross Profit
Depreciation & Amortization	$102.3K	$54.21K	$75.37K	$112.4K	$29.70K	$21.80K	$21.33K		$31.59K	$20.00K	$20.00K	$20.00K	$30.00K	$40.00K	$30.00K	$30.00K	$60.00K	$120.0K	$1.170M	$1.200M	$1.190M	$1.160M	$1.140M	$660.0K	$0.00
YoY Change	88.64%	-28.07%	-32.96%	278.55%	36.24%	2.2%			57.95%	0.0%	0.0%	-33.33%	-25.0%	33.33%	0.0%	-50.0%	-50.0%	-89.74%	-2.5%	0.84%	2.59%	1.75%	72.73%
% of Gross Profit
Operating Expenses	13.20M auds	14.75M auds	$15.39M	$13.93M	$12.80M	$8.196M	$7.014M	$8.729M	$17.19M	$20.73M	$12.42M	$5.490M	$6.430M	$5.120M	$8.720M	$13.20M	$11.50M	$12.99M	$15.44M	$11.71M	$6.120M	$6.240M	$4.660M	$1.410M	$80.00K
YoY Change	-10.49%	-4.2%	10.5%	8.86%	56.12%	16.85%	-19.65%	-49.21%	-17.09%	66.91%	126.23%	-14.62%	25.59%	-41.28%	-33.94%	14.78%	-11.47%	-15.87%	31.85%	91.34%	-1.92%	33.91%	230.5%	1662.5%
Operating Profit
YoY Change

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Interest Expense	4.565K auds	2.285K auds	-$297.1K	$333.1K	$349.1K	-$270.9K	-$660.2K	$857.3K	$4.808M	-$810.0K	$0.00	$70.00K	-$160.0K	-$10.00K	$760.0K	-$850.0K	-$150.0K	$220.0K	-$1.830M	-$500.0K	-$280.0K
YoY Change	99.78%	-100.77%	-189.21%	-4.58%	-228.87%	-58.97%	-177.01%	-82.17%	-693.55%		-100.0%	-143.75%	1500.0%	-101.32%	-189.41%	466.67%	-168.18%	-112.02%	266.0%	78.57%
% of Operating Profit
Other Income/Expense, Net	$2.100K	$454.1K	$213.2K					$0.00	$6.317M	$7.850M	$4.490M	$0.00	-$10.00K	$0.00
YoY Change	-99.54%	112.96%						-100.0%	-19.52%	74.83%		-100.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Pretax Income	-$13.70M	-$12.78M	-$15.31M	-$13.46M	-$12.34M	-$8.266M	-$7.542M	-$7.730M	-$5.885M	-$13.33M	-$7.790M	-$5.240M	-$6.430M	-$4.910M	-$7.530M	-$13.56M	-$11.14M	-$11.72M	-$25.01M	-$9.890M	-$4.580M	-$5.450M	-$4.140M	-$1.330M	-$80.00K
YoY Change	7.24%	-16.54%	13.77%	9.07%	49.26%	9.59%	-2.43%	31.34%	-55.85%	71.12%	48.66%	-18.51%	30.96%	-34.79%	-44.47%	21.72%	-4.95%	-53.14%	152.88%	115.94%	-15.96%	31.64%	211.28%	1562.5%
Income Tax	$104.5K	$70.01K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-13.81M auds	-12.85M auds	-$15.31M	-$13.46M	-$12.34M	-$8.266M	-$7.542M	-$7.730M	-$5.885M	-$13.33M	-$7.790M	-$5.240M	-$6.430M	-$4.910M	-$7.530M	-$13.56M	-$11.14M	-$11.72M	-$25.01M	-$9.890M	-$4.580M	-$5.450M	-$4.140M	-$1.330M	-$80.00K
YoY Change	7.47%	-16.08%	13.77%	9.07%	49.26%	9.59%	-2.43%	31.34%	-55.85%	71.12%	48.66%	-18.51%	30.96%	-34.79%	-44.47%	21.72%	-4.95%	-53.14%	152.88%	115.94%	-15.96%	31.64%	211.28%	1562.5%
Net Earnings / Revenue	-83981.23%	-513882.44%	-74029.74%	-78602.8%	-11367.08%	-4108.83%	-5696.44%	-5418.16%	-3327.91%	-3702.78%	-5193.33%	-2757.89%	-4018.75%	-2231.82%	-1751.16%	-2767.35%	-2184.31%	-1116.19%	-943.77%	-426.29%	-251.65%	-689.87%	-796.15%	-1662.5%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$5.340K	-$9.022K	-$15.04K	-$20.04K	-$15.50K	-$14.13K	-$14.48K	-$11.71K	-$31.14K	-$23.00K	-$18.21K	-$25.97K	-$21.58K	-$37.21K	-$77.61K	-$79.15K	-$91.53K	-$203.7K	-$130.6K	-$74.92K	-$94.59K	-$77.98K	-$35.62K	-$2.319K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Cash & Short-Term Investments	$34.81M	$28.12M	$9.197M	$14.40M	$15.24M	$21.88M	$28.59M		$34.17M	$13.35M	$5.640M	$8.840M	$5.230M	$4.310M	$11.23M	$7.460M	$10.06M	$21.45M	$29.58M	$3.460M	$3.590M	$6.860M	$4.470M
YoY Change	23.8%	205.71%	-36.13%	-5.48%	-30.38%	-23.46%			155.96%	136.7%	-36.2%	69.02%	21.35%	-61.62%	50.54%	-25.84%	-53.1%	-27.48%	754.91%	-3.62%	-47.67%	53.47%
Cash & Equivalents	$34.81M	$28.12M	$192.7K	$14.40M	$15.24M	$21.88M	$28.59M										$10.01M	$21.45M	$29.58M	$3.460M	$3.590M	$6.860M	$4.470M
Short-Term Investments														$0.00	$10.76M	$7.000M	$40.00K
Other Short-Term Assets	$1.612M	$1.096M	$578.1K	$631.8K	$266.6K	$329.6K	$276.5K	$160.0K	$60.00K	$110.0K	$70.00K	$90.00K	$70.00K	$190.0K	$240.0K	$120.0K	$70.00K	$570.0K	$70.00K	$50.00K	$60.00K	$170.0K	$320.0K
YoY Change	47.11%	89.53%	-8.49%	136.95%	-19.1%	19.2%	72.86%	166.6%	-45.45%	57.14%	-22.22%	28.57%	-63.16%	-20.83%	100.0%	71.43%	-87.72%	714.29%	40.0%	-16.67%	-64.71%	-46.88%
Inventory
Prepaid Expenses
Receivables	$20.00	$270.00	$12.58K	$4.830M	$3.152M	$3.036M	$4.787M
Other Receivables	$4.725M	$4.277M	$48.74K	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$41.14M	$33.49M	$9.836M	$19.86M	$18.65M	$25.25M	$33.66M	$160.0K	$41.55M	$16.98M	$7.260M	$8.930M	$6.710M	$4.490M	$11.59M	$7.670M	$10.32M	$22.12M	$29.75M	$3.660M	$3.750M	$7.380M	$4.830M
YoY Change	22.86%	240.46%	-50.47%	6.47%	-26.12%	-24.98%	20940.77%	-99.62%	144.7%	133.88%	-18.7%	33.08%	49.44%	-61.26%	51.11%	-25.68%	-53.35%	-25.65%	712.84%	-2.4%	-49.19%	52.8%
Property, Plant & Equipment	$218.5K	$96.81K	$71.37K	$48.75K	$71.42K	$30.82K	$24.23K		$50.00K	$50.00K	$50.00K	$40.00K	$60.00K	$70.00K	$70.00K	$50.00K	$100.0K	$170.0K	$180.0K	$140.0K	$140.0K	$150.0K	$160.0K	$200.0K
YoY Change	125.72%	35.65%	46.4%	-31.74%	131.73%	27.2%			0.0%	0.0%	25.0%	-33.33%	-14.29%	0.0%	40.0%	-50.0%	-41.18%	-5.56%	28.57%	0.0%	-6.67%	-6.25%	-20.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets						$0.00	$43.99K		$40.00K	$40.00K	$40.00K	$40.00K	$40.00K	$40.00K	$40.00K	$0.00
YoY Change						-100.0%			0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Total Long-Term Assets	$218.5K	$96.80K	$71.37K	$48.75K	$71.42K	$30.82K	$68.21K		$90.00K	$90.00K	$80.00K	$80.00K	$90.00K	$110.0K	$110.0K	$50.00K	$100.0K	$170.0K	$11.67M	$12.73M	$13.83M	$14.94M	$16.05M
YoY Change	125.74%	35.63%	46.4%	-31.74%	131.73%	-54.82%			0.0%	12.5%	0.0%	-11.11%	-18.18%	0.0%	120.0%	-50.0%	-41.18%	-98.54%	-8.33%	-7.95%	-7.43%	-6.92%
Total Assets	$41.36M	$33.59M	$9.908M	$19.91M	$18.73M	$25.28M	$33.73M		$41.64M	$17.07M	$7.340M	$9.010M	$6.800M	$4.600M	$11.70M	$7.720M	$10.42M	$22.29M	$41.42M	$16.39M	$17.58M	$22.32M	$20.88M	$1.840M
YoY Change
Accounts Payable	$2.689M	$1.449M	$954.0K	$2.718M	$2.055M	$892.4K	$1.749M	$362.5K	$650.0K	$280.0K	$200.0K	$310.0K	$280.0K	$110.0K	$170.0K	$460.0K	$950.0K	$1.240M	$340.0K	$150.0K	$520.0K	$820.0K	$110.0K	$80.00K
YoY Change	85.64%	51.83%	-64.9%	32.25%	130.3%	-48.96%	382.38%	-44.23%	132.14%	40.0%	-35.48%	10.71%	154.55%	-35.29%	-63.04%	-51.58%	-23.39%	264.71%	126.67%	-71.15%	-36.59%	645.45%	37.5%
Accrued Expenses	$2.333M	$1.020M	$1.105M					$2.344M	$2.710M	$1.500M
YoY Change	128.69%	-7.65%						-13.5%	80.67%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$57.63K	$27.75K	$32.88K				$0.00		$100.0K	$870.0K	$300.0K	$290.0K	$0.00	$0.00	$770.0K	$0.00
YoY Change	107.68%	-15.6%							-88.51%	190.0%	3.45%			-100.0%
Total Short-Term Liabilities	$5.820M	$3.068M	$2.715M	$3.320M	$2.644M	$1.590M	$2.357M	$2.707M	$3.950M	$3.100M	$1.710M	$2.080M	$1.500M	$800.0K	$1.740M	$1.740M	$1.620M	$2.650M	$2.710M	$570.0K	$910.0K	$920.0K	$150.0K	$80.00K
YoY Change	89.74%	13.01%	-18.24%	25.58%	66.24%	-32.53%	-12.9%	-31.48%	27.42%	81.29%	-17.79%	38.67%	87.5%	-54.02%	0.0%	7.41%	-38.87%	-2.21%	375.44%	-37.36%	-1.09%	513.33%	87.5%
Long-Term Debt	$59.86K	$37.90K	$870.00	$0.00	$0.00	$0.00	$0.00		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$320.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.840M
YoY Change	57.94%	4256.32%													-100.0%								-100.0%
Other Long-Term Liabilities	$13.75K	$9.770K	$41.51K	$34.98K	$920.00	$440.00	$470.00		$0.00	$0.00	$10.00K	$0.00	$70.00K	$50.00K	$90.00K	$50.00K	$80.00K	$50.00K	$10.00K	$0.00
YoY Change	40.74%	-76.46%	18.67%	3702.17%	109.09%	-6.38%				-100.0%		-100.0%	40.0%	-44.44%	80.0%	-37.5%	60.0%	400.0%
Total Long-Term Liabilities	$73.61K	$47.67K	$42.38K	$34.98K	$920.00	$440.00	$470.00		$0.00	$0.00	$10.00K	$0.00	$70.00K	$50.00K	$90.00K	$370.0K	$80.00K	$50.00K	$10.00K	$0.00	$0.00	$0.00	$0.00	$1.840M
YoY Change	54.42%	12.48%	21.15%	3702.17%	109.09%	-6.38%				-100.0%		-100.0%	40.0%	-44.44%	-75.68%	362.5%	60.0%	400.0%					-100.0%
Total Liabilities	$5.894M	$3.115M	$2.757M	$3.355M	$2.645M	$1.591M	$2.358M		$3.950M	$3.100M	$1.720M	$2.080M	$1.570M	$850.0K	$1.830M	$2.110M	$1.690M	$2.700M	$2.710M	$570.0K	$910.0K	$920.0K	$150.0K	$1.920M
YoY Change	89.2%	13.0%	-17.83%	26.86%	66.25%	-32.53%			27.42%	80.23%	-17.31%	32.48%	84.71%	-53.55%	-13.27%	24.85%	-37.41%	-0.37%	375.44%	-37.36%	-1.09%	513.33%	-92.19%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $15.961 Million

About ALTERITY THERAPEUTICS LTD

Alterity Therapeutics Ltd. is a clinical stage biotechnology company. The company is headquartered in Melbourne, Victoria and currently employs 11 full-time employees. The company went IPO on 2000-03-28. The firm is focused on developing disease modifying treatments for neurodegenerative diseases. The firm's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The firm also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Industry: Pharmaceutical Preparations Peers: KAZIA THERAPEUTICS LTD